GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
1.3k
c/glp1eu·posted 2 years ago by u/elin_lindqvist

pharmacy — 20 things I got wrong before I got it right

Pricing Clean Column ×3 Slow Clap ×2

pharmacy — 20 things I got wrong before I got it right, and I am aware this is a minority view on this board.

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.

1,571 up / 237 down87% upvoted45 commentsid 1uejno17 Apr 2024

45 comments

23 in this archive, depth 5

best — the order this archive was captured in

u/bilal_adebayo206 points·2 years ago

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/fabio_ibarra75 points·2 years ago

private pricing varies enormously between neighbouring countries

replysharereportpermalink
u/patient_labslip_log22 points·2 years ago

What pack size is that price for?

replysharereportpermalink
u/ignacio_silva10 points·2 years ago

a prescription from one member state is not automatically valid in another

replysharereportpermalink
u/zaid_eriksen4 points·2 years ago

the reimbursement criteria are published in most member states

replysharereportpermalink
u/nl_verzekeringMOD99 points·2 years ago

Country added to the title — the answers differ across the union and the thread is unusable without it.

replysharereportpermalink
u/ignacio_vanhecke31 points·2 years ago·edited

Country added to the title — the answers differ across the union and the thread is unusable without it.

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/solene_ilunga90 points·2 years ago

What does the local patient information leaflet say?

replysharereportpermalink
u/chidi_demir70 points·2 years ago

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
load more comments (4) →
u/priya_palacios62 points·2 years ago

Have you read the published reimbursement criteria where you are?

replysharereportpermalink
u/still_here_202638 points·2 years ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
load more comments (2) →
u/renal_outcomes_rnephro-curious40 points·2 years ago

Reimbursed or private?

replysharereportpermalink
u/joaquin_trevino13 points·2 years ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/nabila_ogunleye24 points·2 years ago

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

replysharereportpermalink
u/gallbladder_gary13 points·2 years ago

The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.

replysharereportpermalink
u/viktor_nkemelu4 points·2 years ago

The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.

gallbladder_gary is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/sena_teixeira19 points·2 years ago

I would not treat one pharmacy’s quote as a national price. The variation within a country is often larger than between them.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.